A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis

Clinical trial NCT01715896 · COMPLETED

Trial details

NCT number: NCT01715896
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2013-03-01
Primary completion: 2014-11-01
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.